表紙:細胞解離市場- 世界の産業規模、シェア、動向、競合、機会、予測、2018-2028年
市場調査レポート
商品コード
1309224

細胞解離市場- 世界の産業規模、シェア、動向、競合、機会、予測、2018-2028年

Cell Dissociation Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Product Type, By Tissue, By End User, By Region

出版日: | 発行: TechSci Research | ページ情報: 英文 114 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

細胞解離市場- 世界の産業規模、シェア、動向、競合、機会、予測、2018-2028年
出版日: 2023年07月01日
発行: TechSci Research
ページ情報: 英文 114 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の細胞解離市場は、2024~2028年の予測期間において目覚ましいCAGRで成長すると予想されています。

これは、バイオ医薬品産業における研究の拡大、個別化医療に対する需要の高まり、細胞ベースの研究に対する公共投資や政府投資の増加などの要因によるものです。

感染症の有病率の上昇

人口の間で慢性疾患の有病率が高まっていることが、細胞解離の市場需要を押し上げています。感染症の蔓延は、世界中の人々の間で大きな健康上の懸念となっています。例えば、世界保健機関(WHO)によると、2019年には2億9,600万人が慢性B型肝炎に感染し、毎年約150万人が新たに感染しています。細胞解離は、疾患診断において非常に重要な用途を見出し、それによって予測期間における世界の細胞解離市場の成長に拍車をかけています。例えば、核酸、RNA、DNAの分離につながる細胞解離は、さらにベクターの同定のために分析され、次いで疾患の同定が行われます。無細胞DNAのシーケンスにより、C型肝炎、HIV、B型肝炎、サイトメガロウイルス、ヒトT細胞リンパトロピックウイルスなどの感染症が検出されます。

がん研究への資金と投資の増加

腫瘍組織には様々な細胞が存在するため、様々な細胞サブタイプを特徴付けるために、細胞を用いた分析技術が必要となります。腫瘍組織のさらなる調査や研究を行うには、タンパク質分解酵素で処理し、ボルテックスやピペッティング技術で機械的に分解して、単一細胞にする必要があります。マイクロ流体デバイスのような技術は、消化された組織凝集体を単一細胞に解離するために使用されます。マイクロ流体デバイスの使用により、細胞凝集塊から単一細胞への迅速な解離が可能となり、また完全に生存可能な形態の細胞を得ることができます。マイクロ流体デバイスを用いたこの技術は、酵素を含まない条件でも使用できます。これらの方法は、腫瘍が疑われる組織の単一細胞検出・精製法の保護に役立ち、それによってがん生物学を進歩させ、がん検出における分子診断を強化するための調査範囲を拡大し、予測期間における市場の成長を支えています。

M&Aの増加に伴う資金調達と投資の増加

ライフサイエンスのさまざまな分野で細胞解離の需要が高まっており、研究や治療に幅広く応用されています。市場の成長を促進するため、複数の企業がM&Aを開始しています。例えば、ロシュ・ダイアグノスティックスは2021年3月、GenMark Diagnostics Inc.との提携を発表しました。この買収により、ロシュはジェンマークのePlexプラットフォームを利用できるようになります。ePlexは、たった1つの患者サンプルを使って様々な病気の検査を可能にする最先端の革新技術です。この技術には、細菌やウイルス性疾患、抗生物質耐性の迅速診断など、数多くの用途があります。さらに、インド、中国、ブラジルなどの新興経済諸国は、ライフサイエンス分野の研究開発投資の増加により、市場の需要を支えています。例えば、インドの製薬会社Bioconは2020年に投資を増やし、研究開発に5,879万米ドルを費やしています。

最近の動向

2022年、マーストリヒトで開催された国際質量分析会議において、市場大手のサーモフィッシャーサイエンティフィックは、ハイエンドのバイオ医薬品およびプロテオミクスアプリケーション向けに設計されたOrbitrap Ascend TriBrid装置を発表しました。

利用可能なカスタマイズ

TechSci Researchでは、所定の市場データを使用して、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です:

企業情報

  • 追加市場参入企業(最大5社)の詳細分析とプロファイリング

目次

第1章 概要

  • 市場の定義
  • 市場の範囲
    • 対象市場
    • 調査対象年
    • 主要市場セグメンテーション

第2章 調査手法

  • 調査目的
  • ベースライン調査手法
  • 主要産業パートナー
  • 主要協会と二次情報源
  • 予測手法
  • データの三角測量と検証
  • 仮定と限界

第3章 エグゼクティブサマリー

  • 市場概要
  • 主要市場セグメンテーションの概要
  • 主要市場プレーヤーの概要
  • 主要地域/国の概要
  • 市場促進要因・課題・動向の概要

第4章 顧客の声

第5章 細胞解離の世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別(組織解離・細胞剥離)
    • 製品タイプ別(酵素解離製品、非酵素解離製品、器具・付属品)
    • 組織別(上皮組織、結合組織、その他)
    • エンドユーザー別(バイオテクノロジー企業、製薬企業、学術研究機関、その他)
    • 企業別(2022年)
    • 地域別
  • 製品市場マップ

第6章 アジア太平洋地域の細胞解離市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 製品タイプ別
    • 組織別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第7章 欧州の細胞解離市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 製品タイプ別
    • 組織別
    • エンドユーザー別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 北米の細胞解離市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 製品タイプ別
    • 組織別
    • エンドユーザー別
    • 国別
  • 北米国別分析
    • 米国
    • メキシコ
    • カナダ

第9章 南米の細胞解離市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 製品タイプ別
    • 組織別
    • エンドユーザー別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの細胞解離市場展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェアと予測
    • タイプ別
    • 製品タイプ別
    • 組織別
    • エンドユーザー別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品開発

第13章 競合情勢

  • Business Overview
  • Company Snapshot
  • Products & Services
  • Financials(In case of listed companies)
  • Recent Developments
  • SWOT Analysis
    • BD Biosciences
    • Miltenyi Biotec
    • Thermo Fisher Scientific
    • GE Healthcare
    • Sartorius Group
    • Lonza
    • Danaher Corporation
    • Merck KGaA
    • STEMCELL Technologies
    • QIAGEN

第14章 戦略的提言

目次
Product Code: 15046

Global Cell Dissociation Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing research in biopharmaceutical industries, growing demand for personalized medicine, and rising public and governmental investments in cell-based research.

Cell dissociation is a significant step in several research applications, such as it is used in developing vaccines and in cell expansion.

Moreover, the rising development in advanced tissue dissociation, increased development & research studies in stem cell research, along with easy differentiation in enzyme-free dissociation products over the enzymatic dissociation products, etc., are factors that are supporting the market growth and are expected to propel it in the forecast period.

Rising Prevalence of Infectious Diseases

The growing prevalence of chronic diseases among the population is propelling the market demand for cell dissociation. The growing prevalence of infectious diseases is a major health concern among people around the world. For instance, according to the World Health Organization (WHO), 296 million people were affected with chronic hepatitis B infection in 2019, with around 1.5 million new infections developing each year. Cell dissociation founds a very significant application in disease diagnosis and thereby adds to the global cell dissociation market growth in the forecast period. For instance, cell dissociation leading to isolation of the nucleic acids, RNA and DNA, is further analyzed for identification of the vector and followed by the identification of the disease. Sequencing of cell-free DNA can result in the detection of infectious diseases such as hepatitis C, HIV, hepatitis B, cytomegalovirus, and human T-cell lymphotropic virus.

Increasing funding & investments for cancer research

Tumor tissues hold a distinct cell range, requiring several cell-based analysis techniques to characterize different cell subtypes. To undergo further research or study of the tumor tissue, it needs to be dissociated into single cells by undergoing treatments with proteolytic enzymes, which is followed by mechanical breakdown using vortexing or pipetting techniques. Techniques such as microfluidic devices are used for the dissociation of digested tissue aggregate into single cells. The microfluidic device usage results in the quick dissociation of cell aggregate into single cells and also results in obtaining cells in fully viable forms. This technique using microfluidic devices can also be used in enzyme-free conditions. These methods thus aid in the protection of single cell detection and purification methods for tumor-suspecting tissue and thereby enhancing the research scope for advancing cancer biology and enhancing molecular diagnosis in cancer detection, thereby supporting the market growth in the forecast period.

Increase in Funding & Investments Along with Rising Mergers & Acquisitions

There is a growing demand for cell dissociation in multiple fields of life sciences, having a wide range of research and therapeutic applications. Several companies have started mergers and acquisitions to propel the growth of the market. For instance, in March 2021, Roche Diagnostics, announced its partnership with GenMark Diagnostics Inc. Through the acquisition, Roche will have access to GenMark's ePlex platform, a cutting-edge innovation that enables testing for a variety of diseases using just one patient sample. Numerous uses of this technique include the quick diagnosis of bacterial and viral illnesses as well as antibiotic resistance. Additionally emerging economies such as India, China, Brazil, etc. are adding to support the market demand with increased rise in investment in research & development in life sciences. For instance, Indian pharmaceutical company Biocon increased investment and spent USD 58.79 million on research & development in 2020.

Recent Developments

In 2022, one of the leading market players, Thermo Fisher Scientific, at the international mass spectroscopy conference in Maastricht, launched the Orbitrap Ascend TriBrid instrument designed for high-end biopharma and proteomic applications.

Market Segmentation

Global Cell Dissociation Market is segmented based on the type, product type, tissue, end user, region, and competitive landscape. Based on the type, the market is further segmented into tissue dissociation & cell detachment. Based on the product type, the market is segmented into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories. Based on tissue, the market is further fragmented into epithelial tissue, connective tissue, and others. Depending on the end user, the market is segmented into Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes, and others. Based on the region, the Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

BD Biosciences, Miltenyi Biotec, Thermo Fisher Scientific, GE Healthcare, Sartorius Group, Lonza, Danaher Corporation, Merck KGaA, STEMCELL Technologies, and QIAGEN., etc.., are some of the major players operating in the Global Cell Dissociation Market.

Report Scope

In this report, Global Cell Dissociation Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Cell Dissociation Market, By Type:

  • Tissue Dissociation
  • Cell Detachment

Cell Dissociation Market, By Product Type:

  • Enzymatic Dissociation Products
  • Non-Enzymatic Dissociation Products
  • Instruments & Accessories

Cell Dissociation Market, By Tissue:

  • Epithelial Tissue
  • Connective Tissue
  • Others

Cell Dissociation Market, By End User:

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Academic and Research Institutes
  • Others

Cell Dissociation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Cell Dissociation Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Dissociation Market Outlook.

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Tissue Dissociation & Cell Detachment)
    • 5.2.2. By Product Type (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, and Instruments & Accessories)
    • 5.2.3. By Tissue (Epithelial Tissue, Connective Tissue, and Others)
    • 5.2.4. By End user (Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes and others)
    • 5.2.5. By Company (2022)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Global Cell Dissociation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. Type
    • 6.2.2. Product Type
    • 6.2.3. Tissue
    • 6.2.4. End user
    • 6.2.5. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Global Cell Dissociation Market Outlook.
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. Type
        • 6.3.1.2.2. Product Type
        • 6.3.1.2.3. Tissue
        • 6.3.1.2.4. End user
    • 6.3.2. India Global Cell Dissociation Market Outlook.
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. Type
        • 6.3.2.2.2. Product Type
        • 6.3.2.2.3. Tissue
        • 6.3.2.2.4. End user
    • 6.3.3. South Korea Global Cell Dissociation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. Type
        • 6.3.3.2.2. Product Type
        • 6.3.3.2.3. Tissue
        • 6.3.3.2.4. End user
    • 6.3.4. Japan Global Cell Dissociation Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. Type
        • 6.3.4.2.2. Product Type
        • 6.3.4.2.3. Tissue
        • 6.3.4.2.4. End user
    • 6.3.5. Australia Global Cell Dissociation Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. Polymer Type
        • 6.3.5.2.2. Application
        • 6.3.5.2.3. Tissue
        • 6.3.5.2.4. Technique

7. Europe Global Cell Dissociation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. Type
    • 7.2.2. Product Type
    • 7.2.3. Tissue
    • 7.2.4. End user By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Global Cell Dissociation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. Type
        • 7.3.1.2.2. Product Type
        • 7.3.1.2.3. Tissue
        • 7.3.1.2.4. End user
    • 7.3.2. Germany Global Cell Dissociation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. Type
        • 7.3.2.2.2. Product Type
        • 7.3.2.2.3. Tissue
        • 7.3.2.2.4. End user
    • 7.3.3. United Kingdom Global Cell Dissociation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. Type
        • 7.3.3.2.2. Product Type
        • 7.3.3.2.3. Tissue
        • 7.3.3.2.4. End user
    • 7.3.4. Italy Global Cell Dissociation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. Type
        • 7.3.4.2.2. Product Type
        • 7.3.4.2.3. Tissue
        • 7.3.4.2.4. End user
    • 7.3.5. Spain Global Cell Dissociation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. Type
        • 7.3.5.2.2. Product Type
        • 7.3.5.2.3. Tissue
        • 7.3.5.2.4. End user

8. North America Global Cell Dissociation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. Type
    • 8.2.2. Product Type
    • 8.2.3. Tissue
    • 8.2.4. End user
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Global Cell Dissociation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. Type
        • 8.3.1.2.2. Product Type
        • 8.3.1.2.3. Tissue
        • 8.3.1.2.4. End user
    • 8.3.2. Mexico Global Cell Dissociation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. Type
        • 8.3.2.2.2. Product Type
        • 8.3.2.2.3. Tissue
        • 8.3.2.2.4. End user
    • 8.3.3. Canada Global Cell Dissociation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. Type
        • 8.3.3.2.2. Product Type
        • 8.3.3.2.3. Tissue
        • 8.3.3.2.4. End user

9. South America Global Cell Dissociation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. Type
    • 9.2.2. Product Type
    • 9.2.3. Tissue
    • 9.2.4. End user
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Global Cell Dissociation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. Type
        • 9.3.1.2.2. Product Type
        • 9.3.1.2.3. Tissue
        • 9.3.1.2.4. End user
    • 9.3.2. Argentina Global Cell Dissociation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. Type
        • 9.3.2.2.2. Product Type
        • 9.3.2.2.3. Tissue
        • 9.3.2.2.4. End user
    • 9.3.3. Colombia Global Cell Dissociation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. Type
        • 9.3.3.2.2. Product Type
        • 9.3.3.2.3. Tissue
        • 9.3.3.2.4. End user

10. Middle East and Africa Global Cell Dissociation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. Type
    • 10.2.2. Product Type
    • 10.2.3. Tissue
    • 10.2.4. End user
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Global Cell Dissociation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. Type
        • 10.3.1.2.2. Product Type
        • 10.3.1.2.3. Tissue
        • 10.3.1.2.4. End user
    • 10.3.2. Saudi Arabia Global Cell Dissociation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. Type
        • 10.3.2.2.2. Product Type
        • 10.3.2.2.3. Tissue
        • 10.3.2.2.4. End user
    • 10.3.3. UAE Global Cell Dissociation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. Type
        • 10.3.3.2.2. Product Type
        • 10.3.3.2.3. Tissue
        • 10.3.3.2.4. End user
    • 10.3.4. Kuwait Global Cell Dissociation Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. Type
        • 10.3.4.2.2. Product Type
        • 10.3.4.2.3. Tissue
        • 10.3.4.2.4. End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Developments

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (In case of listed companies)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. BD Biosciences
    • 13.6.2. Miltenyi Biotec
    • 13.6.3. Thermo Fisher Scientific
    • 13.6.4. GE Healthcare
    • 13.6.5. Sartorius Group
    • 13.6.6. Lonza
    • 13.6.7. Danaher Corporation
    • 13.6.8. Merck KGaA
    • 13.6.9. STEMCELL Technologies
    • 13.6.10. QIAGEN

14. Strategic Recommendations